ArticleEJHaem2020
Rituximab maintenance significantly reduces early follicular lymphoma progressions in patients treated with frontline R-CHOP.
Vít Procházka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it